$DT

UBS Adjusts Price Target on Dynatrace to $74 From $65, Maintains Buy Rating

UBS raised its price target for Dynatrace to $74 from $65 while maintaining a buy rating. The stock is currently trading at $59.17, up 2.48% on the day but down 0.30% year-to-date. The company has seen a 34.99% increase over the past year.

Original reporting
Published Oct 1, 2026, 1:31 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 1, 2026, 2:01 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$DT
Bullish
high confidence
Mentioned
$DT
Relevance
6/10
AlphAI data visualization · based on marketscreener.com
Decision brief

The 30-second read

$DTBullishMed
01

Why it matters

The price‑target hike signals UBS expects stronger growth or profitability, which could attract short‑term buying.

02

Market read

Analyst target upgrades are a common catalyst for modest price moves in mid‑cap tech stocks.

03

What to watch

Potential competitive pressure from larger cloud monitoring players.

Relevance 6/10Novelty 6/10Timing: pre‑market today

Background

Dynatrace provides software intelligence for cloud applications; UBS maintains a Buy stance.

Company-level read

Ticker impact

$DTBullishHigh confidence
Context

UBS raised Dynatrace's price target to $74 from $65, maintaining a Buy rating.

Expected impact

likely upward pressure as investors price in the higher target.

Evidence & confidence

UBS's upgrade reflects improved outlook; such target hikes typically prompt buying interest.

Market effects

May lift sentiment in the software‑as‑a‑service sector.

Limited to US tech equities.

Minor, confined to investors tracking analyst coverage.

Counterpoint

The target raise could be premature if upcoming earnings miss expectations.

Key entities

  • Dynatrace

    Software intelligence provider (ticker DT).

  • UBS

    Investment bank issuing the price‑target update.

Related articles

$SWKSHighAI 9/10

Tech M&A deals: Skyworks Solutions, Dynatrace, ECARX

Skyworks Solutions completed its merger with Qorvo, creating a $22 billion RF semiconductor company. Qorvo shareholders received $32.50 in cash plus 0.960 Skyworks shares per Qorvo share. The combined company, trading as SWKS, expects $500 million in annual cost synergies. Dynatrace acquired Arize AI for $915 million, adding AI observability capabilities to its platform.

$DTHighAI 9/10

Dynatrace’s $915M Arize deal bets AI agents are just another app to monitor

Dynatrace completed its $915M acquisition of Arize, integrating AI agent monitoring with its existing application and infrastructure monitoring. Arize's tools, including Phoenix, will complement Dynatrace's offerings, addressing AI app performance and cost. Both companies already use AI agents to propose fixes, with Arize accepting 65-70% of automated pull requests. The deal removes an independent AI observability vendor from the market, previously backed by Datadog.

$DTMed

Dynatrace, Inc. (DT) Completes Acquisition of Arize

Dynatrace, Inc. (DT) has finalized its acquisition of Arize, aiming to enhance its platform with AI observability and evaluation features. The company plans to integrate Arize's capabilities into its existing offerings. According to Dynatrace, this move is part of a strategy to expand its AI observability footprint amid growing enterprise AI adoption.

$DTHigh

UBS raises Dynatrace stock price target to $74 on AI demand

UBS raised Dynatrace's (DT) price target to $74 from $65, citing AI demand and the Arize acquisition. The stock trades near its 52-week high at $58.90. UBS projects 19% revenue growth for FY2027-2029, with AI observability driving demand. Other analysts also upgraded DT, highlighting strong market demand and growth potential.

$XENEHigh

Premarket movers: Xenon sinks on trial pause, Netflix hit by downgrade

U.S. stock futures rose Friday. Xenon Pharmaceuticals (XEN) fell 24% after pausing trials. Netflix (NFLX) dropped 2.1% following a downgrade and price target cut by Wells Fargo. Array Technologies (ARRY) declined 3.1% after a downgrade and lower price target from UBS. Steel Dynamics (STLD) fell 3.4% on below-expectation earnings guidance. Frontline (FRO) dropped 6% ex-dividend. StubHub (ETSY) rose 3.5% on an upgrade from Citi. Dynatrace (DT) gained 1.2% after an upgrade from Needham. Etsy (ETSY)